Modulation of experimental systemic lupus erythematosus.
作者信息
Mozes E, Segal R, Sthoeger Z, Dayan M, Zinger H, Kohn L D, Singer D S
机构信息
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
出版信息
Isr J Med Sci. 1996 Jan;32(1):19-21.
PMID:8550341
Abstract
摘要
相似文献
1
Modulation of experimental systemic lupus erythematosus.实验性系统性红斑狼疮的调节
Isr J Med Sci. 1996 Jan;32(1):19-21.
2
The beneficial effect of the estrogen antagonist tamoxifen on experimental systemic lupus erythematosus.雌激素拮抗剂他莫昔芬对实验性系统性红斑狼疮的有益作用。
J Rheumatol. 1995 Aug;22(8):1606-7.
3
Immunosuppression and immunomodulation of experimental models of systemic lupus erythematosus and antiphospholipid syndrome.系统性红斑狼疮和抗磷脂综合征实验模型的免疫抑制与免疫调节
Transplant Proc. 1996 Dec;28(6):3096-8.
4
Update on experimental systemic lupus erythematosus.实验性系统性红斑狼疮的最新进展。
Isr J Med Sci. 1992 Feb;28(2):136-8.
5
Systemic lupus erythematosus.系统性红斑狼疮
Am Fam Physician. 2007 Nov 1;76(9):1351-3.
6
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.甲氨蝶呤对系统性红斑狼疮的激素节省作用：一项双盲、随机、安慰剂对照试验。
Arthritis Rheum. 2008 Dec 15;59(12):1796-804. doi: 10.1002/art.24068.
7
Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.甲氨蝶呤治疗难治性儿童期起病的系统性红斑狼疮
J Rheumatol. 1998 Mar;25(3):572-5.
8
Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus.甲氨蝶呤治疗对小鼠实验性系统性红斑狼疮细胞因子的调控作用
J Rheumatol. 1997 Jun;24(6):1075-82.
9
[Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].[银屑病与系统性红斑狼疮：一种伴有特定治疗问题的罕见关联]
Ann Med Interne (Paris). 2003 Feb;154(1):3-6.
10
Accelerated nodulosis during methotrexate therapy in a patient with systemic lupus erythematosus and Jaccoud's arthropathy.一名患有系统性红斑狼疮和雅库病性关节病的患者在甲氨蝶呤治疗期间出现加速性结节病。
Rheumatology (Oxford). 2004 Dec;43(12):1587-8. doi: 10.1093/rheumatology/keh393.
Zotero 插件